Biotechnology
India is ranked 12th in the world in biotech and third in Asia-Pacific.

Indian Biotechnology Industry Analysis

Latest update: January, 2016

Robust growth in Biotech industry

• Maintaining the momentum of the previous years, the Indian   biotech industry grew 16.28 per cent in FY14; the total industry   size was US$ 5 billion at the end of the financial year and it   reached US$ 7 billion in FY15. 

• Fast-paced growth is likely to continue; the industry is expected   to increase in size to USD11.6 billion by 2017, driven by a range   of factors such as growing demand, intensive R&D activities and   strong government initiatives 

Domestic market share of Indian auto component industry

Bio-pharma accounts for majority market share

• The bio-pharmaceutical segment accounted for the largest share   of the biotech industry, with 62.0 per cent of total revenues in   FY15. Revenue from bio-pharma exports reached US$ 2.2 billion   in 2013, accounting for 51 per cent of total revenues of the   biotech industry.

• The bio-services segment recorded the highest growth 11.78 per   cent in FY14, followed by bio-informatics (7.9 per cent) and   biopharma (6.23 per cent).

Auto components sector contribution to GDP

 

Last Updated: January, 2016

India is among the top 12 biotech destinations in the world and ranks second in Asia, after China. The Indian biotech industry is likely to experience significant growth on the back of increasing economic prosperity, health consciousness and a billion-plus population base. Current estimates value the industry at US$ 7 billion in FY15, which is expected to grow at 30.46 per cent Compound Annual Growth Rate (CAGR) to US$ 100 billion by FY25.

The sector is divided into five major segments: bio-pharma, bio-services, bio-agri, bio-industrial and bio-informatics. Biotechnology industry’s growth in India is primarily driven by vaccines and recombinant therapeutics. Going forward, India also has the potential to become a major producer of transgenic rice and several Genetically Modified (GM) or engineered vegetables.

The Government of India has taken several initiatives including a biotechnology industry partnership program to develop new technologies and launched a National Rural Healthcare Mission to boost healthcare spending. As per the 12th Five-Year Plan, the government aims to spend US$ 3.7 billion on biotechnology compared to US$ 1.1 billion in the 11th Five-Year Plan to accelerate the pace of research, innovation and development. In addition, the Department of Biotechnology (DBT) has designed the National Biotechnology Development Strategy (NBDS) to strengthen the industry’s human resources and infrastructure while promoting growth and trade. Furthermore, the Government has allowed 100 per cent Foreign Direct Investment (FDI) through the automatic route for manufacturers of drugs and pharmaceuticals. 

Sectoral Presentation (January, 2016)

Download PDF   Download  (Size: 1.28 MB )

Posters

Brand India Pharma

CATALYSING GROWTH

The Indian biotechnology sector is expected to clock US$ 10 billion in revenue by 2015 on the back of emerging opportunities from around the world.

+ More >

Brand India Pharma

IBEF Publications

IBEF Publication

India Now Magazine


India Now Business and Economy

English

+ More Publications >

IBEF Publication

Blog – Perspectives on India More

Powered by the Who's Who of India

author_Anu_P._Mathai_photo_1_-_mobile_photo_1.jpg Indian film industry to reach US$ 3.7 billion by 2020
Anu P. Mathai, IES, Chief Executive Officer, IBEF

The Indian film industry is expected to grow at a compounded annual growth rate (CAGR) of 11 per cent to reach US$ 3.7 billion by 2020, according to a recently released r...

author_Narayan_51.jpg Decoding GST for manufacturing SMEs
Mr. R. Narayan, Founder & CEO, Power2SME

As the eagerly and anxiously awaited Goods and Services Tax (GST) Bill, 2016 sailed through the Rajya Sabha with two-thirds majority in which 203 members voted i...

author_shobhit-jain1.jpg India: Unlocking our skies
Dr. Shobhit Jain, IRS, Deputy CEO IBEF

In a major boost to regional air connectivity, the Government of India has recently announced that it plans to set up 50 new airports in the country over the next three y...

author_ravi-capoor1.jpg GST: Great Step of Transformation
Ravi Capoor, IAS, Chief Executive Officer, IBEF

The much-awaited Constitution Amendment Bill for Goods and Services Tax (GST) was passed in the Parliament recently and is expected to be implemented by April 2017 replac...

author_Narayan_51.jpg Making SMEs bankable and banking on SMEs
Mr. R. Narayan, Founder & CEO, Power2SME

India is considered a "bright spot" in the gloomy, global economic scenario today. The country with a GDP growth of 7.6% (in 2015-16) has topped the World Bank'...

author_ravi-capoor1.jpg Brand India Engineering at INNOPROM 2016
Ravi Capoor, IAS, Chief Executive Officer, IBEF

India successfully showcased its strengths in the field of engineering at the flagship Russian international trade fair, INNOPROM 2016 held at Yekaterinburg, Russia from ...

ideas More

Ideas

A Big Step Forward
Krispian Lawrence co-founded Ducere Technologies with Anirudh Sharma in 2011. Lechal is the outcome of their concerted efforts to use haptics in the wearable technology space. Both Anirudh and I were always fascinated by wearable technology, and were tinkering with various ideas in this space. But the concept was nascent...

JOIN IBEF.org

Join IBEF.org now. Enjoy FREE subscriptions downloads, updates and more.

Error

Already a member?
Login / Retrieve Password

x IBEF : India Brand Equity Foundation